Doug Kass shares his thoughts on Treasury notes and bonds, and offers some other observations.
South Korea's Samsung Bioepis is looking to sell its version of the drug in the U.S.
A bearish momentum indicator is about to be formed.
Company officials conducted a pharmaceutical business review meeting with industry analysts on Wednesday.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.